Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Middle Tennessee State University has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to examiner KIM, SEONG JONG, who is the busiest examiner for the portfolio with 1 pending action. The prosecution is currently confined to 1 distinct examiner and 1 distinct art unit. This narrow focus suggests a specialized application within the biotech field.
Practitioners must address the specific technical requirements of this examiner to advance the application. Because there is only 1 distinct examiner involved, the university's immediate patent outcomes depend entirely on the individual discretion of KIM, SEONG JONG. This lack of examiner diversity means the prosecution strategy must be precisely tailored to the specific requirements of the assigned art unit. The presence of only 1 distinct art unit suggests that the research and development in this area is highly specialized. Success in this pending action will require a thorough understanding of the specific examination standards applied within this technical group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18695490 | ANTIMICROBIAL COMPOUNDS AND THE METHODS OF USE | KIM, SEONG JONG | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18695490 | ANTIMICROBIAL COMPOUNDS AND THE METHODS OF USE | KIM, SEONG JONG | 1621 | §102§103§112 | Non-Final OA | — | Pending | Mar 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial